pubmed-article:7531596 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0152314 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C1708726 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0022614 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0079883 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0279023 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C0439799 | lld:lifeskim |
pubmed-article:7531596 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
pubmed-article:7531596 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:7531596 | pubmed:dateCreated | 1995-3-14 | lld:pubmed |
pubmed-article:7531596 | pubmed:abstractText | Norepinephrine (NE)-induced potentiation of the perforant path-evoked potential is blocked by N-methyl-D-aspartate (NMDA) receptor antagonism in vitro. Does this occur in vivo? A saline and a ketamine micropipette monitored perforant path-evoked potentials in the dentate gyrus of urethane-anesthetized rats. Activation of locus coeruleus (LC) produced short- and long-term potentiation of the perforant path-evoked potential on both pipettes. Spike amplitude potentiation was enhanced on the ketamine pipette. In contrast high frequency-induced potentiation on the ketamine pipette was attenuated. LC-NE potentiation may not require NMDA channel activation in vivo. | lld:pubmed |
pubmed-article:7531596 | pubmed:language | eng | lld:pubmed |
pubmed-article:7531596 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7531596 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7531596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7531596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7531596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7531596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7531596 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7531596 | pubmed:month | Nov | lld:pubmed |
pubmed-article:7531596 | pubmed:issn | 0006-8993 | lld:pubmed |
pubmed-article:7531596 | pubmed:author | pubmed-author:HarleyC WCW | lld:pubmed |
pubmed-article:7531596 | pubmed:author | pubmed-author:FrizzellL MLM | lld:pubmed |
pubmed-article:7531596 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7531596 | pubmed:day | 7 | lld:pubmed |
pubmed-article:7531596 | pubmed:volume | 663 | lld:pubmed |
pubmed-article:7531596 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7531596 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7531596 | pubmed:pagination | 173-8 | lld:pubmed |
pubmed-article:7531596 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:meshHeading | pubmed-meshheading:7531596-... | lld:pubmed |
pubmed-article:7531596 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7531596 | pubmed:articleTitle | The N-methyl-D-aspartate channel blocker ketamine does not attenuate, but enhances, locus coeruleus-induced potentiation in rat dentate gyrus. | lld:pubmed |
pubmed-article:7531596 | pubmed:affiliation | Psychology Department, Memorial University of Newfoundland, St. John's, Canada. | lld:pubmed |
pubmed-article:7531596 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7531596 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:7531596 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |